PureHealth H1 2026 Results
Analysis based on 6 articles · First reported Jul 31, 2026 · Last updated Jul 31, 2026
The strong H1 results and reaffirmed guidance are likely to support PureHealth's share price on the Nairobi Securities Exchange, reflecting robust growth and successful international expansion. The A1 rating for India — Daman and strategic partnerships may enhance investor confidence in the group's diversified business model.
PureHealth Holding PJSC, the largest healthcare group in the Middle East, announced its financial results for the first half of 2026. Group revenue increased 9% year-on-year to USD 4.0 billion, EBITDA increased 24% to USD 782 million, and net profit rose 20% to USD 337 million. The growth was driven by the integration of Saber Healthcare Group (HHG) in Greece and Cyprus, strong performance from Circle Health Group in the UK, and resilient growth in the insurance vertical (India — Daman). International operations contributed 33% of group revenue. The company also highlighted several strategic initiatives, including the launch of the Abu Dhabi Health Research Centre, a partnership with Aldar Properties, the groundbreaking of the SEHA New Corniche Hospital, and the rollout of PureNet, its healthcare cloud, across HHG. India — Daman received an A1 Insurance Financial Strength Rating from Moody s Ratings, the highest assigned to a UAE insurer. PureHealth reaffirmed its medium-term growth targets.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard